NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|754497788|emb|CDM88727|]
View 

putative NAD(P)H oxidoreductase [Xenorhabdus bovienii]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
PubMed:  25372605|7568029
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
2-193 1.35e-56

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 177.34  E-value: 1.35e-56
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   2 HALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEGFDPRFTESDiaaFYKESLPPVDVIAEQSRIALADAL 81
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHE--VTVHDLYAEGFDPVLSAAD---FYRDGPLPIDVAAEQELLLWADHL 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  82 VLVYPVYWWTMPALLKGWIDRVFCHGWAYnEHPDGRLEKKLQHLPVHLVAIGAAGRETYLKHGFWDAMKTQIDHGIFDYC 161
Cdd:COG2249   76 VFQFPLWWYSMPALLKGWIDRVLTPGFAY-GYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLFRGTLGYC 154
                        170       180       190
                 ....*....|....*....|....*....|..
gi 754497788 162 GAPVITSELLLHPELKDTNAYQEAAYDIGRHI 193
Cdd:COG2249  155 GMKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
2-193 1.35e-56

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 177.34  E-value: 1.35e-56
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   2 HALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEGFDPRFTESDiaaFYKESLPPVDVIAEQSRIALADAL 81
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHE--VTVHDLYAEGFDPVLSAAD---FYRDGPLPIDVAAEQELLLWADHL 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  82 VLVYPVYWWTMPALLKGWIDRVFCHGWAYnEHPDGRLEKKLQHLPVHLVAIGAAGRETYLKHGFWDAMKTQIDHGIFDYC 161
Cdd:COG2249   76 VFQFPLWWYSMPALLKGWIDRVLTPGFAY-GYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLFRGTLGYC 154
                        170       180       190
                 ....*....|....*....|....*....|..
gi 754497788 162 GAPVITSELLLHPELKDTNAYQEAAYDIGRHI 193
Cdd:COG2249  155 GMKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
1-193 1.07e-40

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 136.69  E-value: 1.07e-40
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788    1 MHALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEgFDPRFTESDIAAF-YKEslPPVDVIAEQSRIALAD 79
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEALKAAGHE--VTVRDLYAL-FLPVLDAEDLADLtYPQ--GAADVESEQEELLAAD 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   80 ALVLVYPVYWWTMPALLKGWIDRVFCHGWAYNEHPDGRLEKKLQHLPVHLVAIGAAGRETYLKHGF-WDAMKTQI--DHG 156
Cdd:pfam02525  76 VIVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYEEGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYnGFSLDELLpyLRG 155
                         170       180       190
                  ....*....|....*....|....*....|....*...
gi 754497788  157 IFDYCGAPVITSELLL-HPELKDTNAYQEAAYDIGRHI 193
Cdd:pfam02525 156 ILGFCGITDLPPFAVEgTAGPEDEAALAEALERYEERL 193
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-192 8.25e-34

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 119.42  E-value: 8.25e-34
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   1 MHALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEGFDPRFTESDIAAFYKESLP-PVDVIAEQSRIALAD 79
Cdd:PRK09739   4 MRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQ--VEELDLYRSGFDPVLTPEDEPDWKNPDKRySPEVHQLYSELLEHD 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  80 ALVLVYPVYWWTMPALLKGWIDRVFCHGWAYNEhpdgrlEKKLQHLPVHLVAIGAAGRETYLKHGfWDAMKTQ-IDHGIF 158
Cdd:PRK09739  82 ALVFVFPLWWYSFPAMLKGYIDRVWNNGLAYGD------GHKLPFNKVRWVALVGGSKESFVKRG-WEKNMSDyLNVGMA 154
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|..
gi 754497788 159 DYCGAPVITSELL---LHPELKDTNA--YQ---EAAYDIGRH 192
Cdd:PRK09739 155 SYLGIEDSDVTFLyntLVFDGEELHAshYQsllSQAREMVDA 196
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
2-193 1.35e-56

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 177.34  E-value: 1.35e-56
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   2 HALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEGFDPRFTESDiaaFYKESLPPVDVIAEQSRIALADAL 81
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHE--VTVHDLYAEGFDPVLSAAD---FYRDGPLPIDVAAEQELLLWADHL 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  82 VLVYPVYWWTMPALLKGWIDRVFCHGWAYnEHPDGRLEKKLQHLPVHLVAIGAAGRETYLKHGFWDAMKTQIDHGIFDYC 161
Cdd:COG2249   76 VFQFPLWWYSMPALLKGWIDRVLTPGFAY-GYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLFRGTLGYC 154
                        170       180       190
                 ....*....|....*....|....*....|..
gi 754497788 162 GAPVITSELLLHPELKDTNAYQEAAYDIGRHI 193
Cdd:COG2249  155 GMKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
1-193 1.07e-40

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 136.69  E-value: 1.07e-40
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788    1 MHALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEgFDPRFTESDIAAF-YKEslPPVDVIAEQSRIALAD 79
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEALKAAGHE--VTVRDLYAL-FLPVLDAEDLADLtYPQ--GAADVESEQEELLAAD 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   80 ALVLVYPVYWWTMPALLKGWIDRVFCHGWAYNEHPDGRLEKKLQHLPVHLVAIGAAGRETYLKHGF-WDAMKTQI--DHG 156
Cdd:pfam02525  76 VIVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYEEGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYnGFSLDELLpyLRG 155
                         170       180       190
                  ....*....|....*....|....*....|....*...
gi 754497788  157 IFDYCGAPVITSELLL-HPELKDTNAYQEAAYDIGRHI 193
Cdd:pfam02525 156 ILGFCGITDLPPFAVEgTAGPEDEAALAEALERYEERL 193
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-192 8.25e-34

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 119.42  E-value: 8.25e-34
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   1 MHALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKEGFDPRFTESDIAAFYKESLP-PVDVIAEQSRIALAD 79
Cdd:PRK09739   4 MRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQ--VEELDLYRSGFDPVLTPEDEPDWKNPDKRySPEVHQLYSELLEHD 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  80 ALVLVYPVYWWTMPALLKGWIDRVFCHGWAYNEhpdgrlEKKLQHLPVHLVAIGAAGRETYLKHGfWDAMKTQ-IDHGIF 158
Cdd:PRK09739  82 ALVFVFPLWWYSFPAMLKGYIDRVWNNGLAYGD------GHKLPFNKVRWVALVGGSKESFVKRG-WEKNMSDyLNVGMA 154
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|..
gi 754497788 159 DYCGAPVITSELL---LHPELKDTNA--YQ---EAAYDIGRH 192
Cdd:PRK09739 155 SYLGIEDSDVTFLyntLVFDGEELHAshYQsllSQAREMVDA 196
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
66-110 1.37e-11

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 60.57  E-value: 1.37e-11
                         10        20        30        40
                 ....*....|....*....|....*....|....*....|....*
gi 754497788  66 VDVIAEQSRIALADALVLVYPVYWWTMPALLKGWIDRVFCHGWAY 110
Cdd:PRK00871  44 IDIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWAY 88
FMN_red pfam03358
NADPH-dependent FMN reductase;
1-166 1.30e-09

NADPH-dependent FMN reductase;


Pssm-ID: 427259 [Multi-domain]  Cd Length: 152  Bit Score: 54.55  E-value: 1.30e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788    1 MHALIVISHPISDSLSGHVAQYIADGITQS-NPEnSVELADLAKEGFDPRFTESDIaafykeslPPVDVIAEQSRIALAD 79
Cdd:pfam03358   1 MKILAISGSPRKGSNTRKLARWAAELLEEGaEVE-LIDLADLILPLCDEDLEEEQG--------DPDDVQELREKIAAAD 71
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   80 ALVLVYPVYWWTMPALLKGWIDRVFChgwAYNEHPdgrlekkLQHLPVHLVAIGAAGRetylkHGFWDAMKTQIdhgIFD 159
Cdd:pfam03358  72 AIIIVTPEYNGSVSGLLKNAIDWLSR---LRGGKE-------LRGKPVAIVSTGGGRS-----GGLRAVEQLRQ---VLA 133

                  ....*..
gi 754497788  160 YCGAPVI 166
Cdd:pfam03358 134 ELGAIVV 140
SsuE COG0431
NAD(P)H-dependent FMN reductase [Energy production and conversion];
1-173 4.48e-08

NAD(P)H-dependent FMN reductase [Energy production and conversion];


Pssm-ID: 440200 [Multi-domain]  Cd Length: 162  Bit Score: 50.54  E-value: 4.48e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   1 MHALIVISHPISDSLSGHVAQYIADGITQSNPEnsVELADLAKegFDPRFTESDIAAFYkeslPPVDVIAEQSRIALADA 80
Cdd:COG0431    1 MKILVISGSLRPGSFNRKLARAAAELAPAAGAE--VELIDLRD--LDLPLYDEDLEADG----APPAVKALREAIAAADG 72
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  81 LVLVYPVYWWTMPALLKGWIDrvfchgWAYNEHpdgrlekkLQHLPVHLVAIGAAGRetylkHGFW--DAMKTqidhgIF 158
Cdd:COG0431   73 VVIVTPEYNGSYPGVLKNALD------WLSRSE--------LAGKPVALVSTSGGAR-----GGLRalEHLRP-----VL 128
                        170
                 ....*....|....*
gi 754497788 159 DYCGAPVITSELLLH 173
Cdd:COG0431  129 SELGAVVLPPQVSIP 143
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
4-198 2.83e-07

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 48.39  E-value: 2.83e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   4 LIVISHpiSDSLSGHV---AQYIADGITQSNPEnsVELADLAKEGFDPRftesdIAAFYKESLPPVDVIAE-QSRIALAD 79
Cdd:COG0655    2 ILVING--SPRKNGNTaalAEAVAEGAEEAGAE--VELIRLADLDIKPC-----IGCGGTGKCVIKDDMNAiYEKLLEAD 72
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788  80 ALVLVYPVYWWTMPALLKGWIDRVFCHgwaynEHPDGRLEKKlqhlPVHLVAIGAAGRETYLKHGFWDAMKTQ--IDHGI 157
Cdd:COG0655   73 GIIFGSPTYFGNMSAQLKAFIDRLYAL-----WAKGKLLKGK----VGAVFTTGGHGGAEATLLSLNTFLLHHgmIVVGL 143
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|.
gi 754497788 158 FDYCGAPVITSELLLHPELKDTnayqeaAYDIGRHIFSMAE 198
Cdd:COG0655  144 PPYGAVGGGGPGDVLDEEGLAT------ARELGKRLAELAK 178
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
66-110 3.10e-06

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 45.76  E-value: 3.10e-06
                         10        20        30        40
                 ....*....|....*....|....*....|....*....|....*
gi 754497788  66 VDVIAEQSRIALADALVLVYPVYWWTMPALLKGWIDRVFCHGWAY 110
Cdd:PRK04930  50 IDIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDRVLSRGFAS 94
PRK00170 PRK00170
azoreductase; Reviewed
1-103 1.83e-05

azoreductase; Reviewed


Pssm-ID: 234675 [Multi-domain]  Cd Length: 201  Bit Score: 43.73  E-value: 1.83e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 754497788   1 MHALIVISHPISD-SLSGHVAQYIADGITQSNPENSVELADLAKEGFdPRFTESDIAAFYK--ESLPPvdviAEQSRIAL 77
Cdd:PRK00170   2 SKVLVIKSSILGDySQSMQLGDAFIEAYKEAHPDDEVTVRDLAAEPI-PVLDGEVVGALGKsaETLTP----RQQEAVAL 76
                         90       100       110
                 ....*....|....*....|....*....|....*.
gi 754497788  78 ----------ADALVLVYPVYWWTMPALLKGWIDRV 103
Cdd:PRK00170  77 sdelleeflaADKIVIAAPMYNFSIPTQLKAYIDLI 112
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH